Condensed Consolidated Interim Financial Statements as of June 30, 2018

Bayer Group
Consolidated Income Statements

 

 

Q2 2017

 

Q2 2018

 

H1 2017

 

H1 2018

 

 

€ million

 

€ million

 

€ million

 

€ million

2017 figures restated

1

For definition see Annual Report 2017, Chapter “Alternative Performance Measures Used by the Bayer Group.”

2

Weighted average number of shares (basic and diluted) restated for all periods prior to June 2018 to reflect the effect of the bonus component of the subscription rights issued as part of the June 2018 capital increase

Net sales

 

8,714

 

9,481

 

18,394

 

18,619

Cost of goods sold

 

(2,783)

 

(3,512)

 

(5,770)

 

(6,421)

Gross profit

 

5,931

 

5,969

 

12,624

 

12,198

Selling expenses

 

(2,831)

 

(2,940)

 

(5,498)

 

(5,449)

Research and development expenses

 

(1,097)

 

(1,261)

 

(2,191)

 

(2,301)

General administration expenses

 

(493)

 

(573)

 

(953)

 

(1,000)

Other operating income

 

185

 

185

 

344

 

337

Other operating expenses

 

(232)

 

(29)

 

(436)

 

(124)

EBIT1

 

1,463

 

1,351

 

3,890

 

3,661

Equity-method income (loss)

 

(5)

 

27

 

(12)

 

98

Financial income

 

100

 

160

 

132

 

530

Financial expenses

 

(464)

 

(509)

 

(785)

 

(820)

Financial result

 

(369)

 

(322)

 

(665)

 

(192)

Income before income taxes

 

1,094

 

1,029

 

3,225

 

3,469

Income taxes

 

(258)

 

(216)

 

(682)

 

(710)

Income from continuing operations after income taxes

 

836

 

813

 

2,543

 

2,759

of which attributable to noncontrolling interest

 

2

 

6

 

 

6

of which attributable to Bayer AG stockholders (net income)

 

834

 

807

 

2,543

 

2,753

Income from discontinued operations after income taxes

 

641

 

(8)

 

1,205

 

of which attributable to noncontrolling interest

 

251

 

 

441

 

of which attributable to Bayer AG stockholders (net income)

 

390

 

(8)

 

764

 

Income after income taxes

 

1,477

 

805

 

3,748

 

2,759

of which attributable to noncontrolling interest

 

253

 

6

 

441

 

6

of which attributable to Bayer AG stockholders (net income)

 

1,224

 

799

 

3,307

 

2,753

 

 

 

 

 

 

 

 

 

 

 

Shares

 

Shares

 

Shares

 

Shares

Weighted average number of shares2

 

885,186,889

 

915,694,644

 

884,826,889

 

900,704,047

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share

 

 

 

 

 

 

 

 

From continuing operations

 

 

 

 

 

 

 

 

Basic

 

0.94

 

0.88

 

2.87

 

3.06

Diluted

 

0.94

 

0.88

 

2.87

 

3.06

From discontinued operations

 

 

 

 

 

 

 

 

Basic

 

0.44

 

(0.01)

 

0.87

 

0.00

Diluted

 

0.44

 

(0.01)

 

0.87

 

0.00

From continuing and discontinued operations

 

 

 

 

 

 

 

 

Basic

 

1.38

 

0.87

 

3.74

 

3.06

Diluted

 

1.38

 

0.87

 

3.74

 

3.06

Compare to Last Year